🔎 Trials Near Me

Utama › Kanser Kolorektal › Mississippi

Kajian klinikal Kanser Kolorektal di Mississippi

6 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi di Mississippi.

Bandar di Mississippi

Teks kajian rasmi (Bahasa Inggeris)

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • dan 2 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05673148

A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer

  • Hattiesburg Clinic, Hattiesburg
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT05379595

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

  • Hattiesburg Clinic, Hattiesburg
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06750094

A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer

  • Hattiesburg Clinic, Hattiesburg
Mengambil pesertaFasa 4
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Jul 2026 · NCT06562543

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle, Columbus
  • Baptist Cancer Center-Grenada, Grenada
  • Baptist Memorial Hospital and Cancer Center-Union County, New Albany
  • dan 2 lagi
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.